Carfilzomib modulates tumor microenvironment to potentiate immune checkpoint therapy for cancer
Qian Zhou(Jinan University), Liang Chen(Shanghai Jiao Tong University), Zhidong Luan(Qujiang People's Hospital), Yadong Huang(Jinan University), Qigui Xu(Qujiang People's Hospital), Sujing Yuan(Shanghai Institutes for Biological Sciences), Jinxia Liang(Jinan University), Meng Xu(First Affiliated Hospital of Jinan University), Jin Liu(Central South University), Bo Li(Guangzhou University of Chinese Medicine), Wensheng Chen(Jinan University), Weida Wang(Chinese Academy of Medical Sciences & Peking Union Medical College), Tong Yang(Jinan University), Penghui Zhou(Sun Yat-sen University), Yingchang Li(Jinan University), Zhongjun Xia(Sun Yat-sen University), Zhenzhen Fan(Jinan University)
Cited by 56
Related Papers
Osteoclast-derived exosomal miR-214-3p inhibits osteoblastic bone formation
|Nature Communications|2016|588
Recent Advances in SELEX Technology and Aptamer Applications in Biomedicine
|International Journal of Molecular Sciences|2017|487
Stress–glucocorticoid–TSC22D3 axis compromises therapy-induced antitumor immunity
|Nature Medicine|2019|367